# Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair

> **NCT02084069** · PHASE3 · COMPLETED · sponsor: **Urmia University of Medical Sciences** · enrollment: 58 (actual)

## Conditions studied

- Heart Valve Diseases

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT02084069
- **Lead sponsor:** Urmia University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084069, "Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02084069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*